CHRS Coherus BioSciences

Watchlist

1.180
+0.020+1.72%

Close Feb 14 16:00 ET

1.190
+0.010+0.85%

Post 19:01 ET

136.75MMarket Cap-13.11P/E (TTM)

About Coherus BioSciences Company

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Company Profile

SymbolCHRS

Company NameCoherus BioSciences

Listing DateNov 6, 2014

Issue Price13.50

Founded2010

CEOMr. Dennis M. Lanfear

MarketNASDAQ

Employees306

Fiscal Year Ends12-31

Address333 Twin Dolphin Drive,Suite 600

CityRedwood City

ProvinceCalifornia

CountryUnited States of America

Zip Code94065

Phone1-650-649-3530

Websitehttp://www.coherus.com

Company Executives

Name
Position
Salary

Dennis M. Lanfear
President, Chief Executive Officer and Chairman of the Board
5.90M

Bryan J. McMichael
Chief Financial Officer and Principal Accounting Officer
1.07M

Paul Reider
Chief Commercial Officer
1.93M

Georgia L. Erbez
Director
--

Rita A. Karachun
Director
--

Dr. Michael Ryan, Pharm.D.
Director
173.61K

Mark D. Stolper
Independent Director
198.69K

Mats L. Wahlstrom
Lead Independent Director
228.69K

Ali J. Satvat
Independent Director
65.00K

Dr. Lee N. Newcomer, M.D.
Independent Director
186.19K

Charles Newton
Independent Director
188.69K

Dr. Jill O’Donnell-Tormey
Independent Director
183.69K

CHRS Coherus BioSciences

About Coherus BioSciences Company

Company Profile

Company Executives

Trending Stocks